Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.920
+0.090 (2.35%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Apyx Medical Revenue
Apyx Medical had revenue of $12.49M in the quarter ending March 31, 2026, with 32.45% growth. This brings the company's revenue in the last twelve months to $55.90M, up 18.22% year-over-year. In the year 2025, Apyx Medical had annual revenue of $52.84M with 9.86% growth.
Revenue (ttm)
$55.90M
Revenue Growth
+18.22%
P/S Ratio
2.94
Revenue / Employee
$272,702
Employees
205
Market Cap
164.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.84M | 4.74M | 9.86% |
| Dec 31, 2024 | 48.10M | -4.25M | -8.11% |
| Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
| Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
| Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
| Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
| Dec 31, 2019 | 28.24M | 11.63M | 70.04% |
| Dec 31, 2018 | 16.61M | 6.37M | 62.25% |
| Dec 31, 2017 | 10.23M | 1.42M | 16.04% |
| Dec 31, 2016 | 8.82M | -20.70M | -70.13% |
| Dec 31, 2015 | 29.52M | 1.84M | 6.64% |
| Dec 31, 2014 | 27.68M | 4.02M | 16.99% |
| Dec 31, 2013 | 23.66M | -4.01M | -14.50% |
| Dec 31, 2012 | 27.67M | 2.26M | 8.89% |
| Dec 31, 2011 | 25.41M | 1.18M | 4.87% |
| Dec 31, 2010 | 24.23M | -2.72M | -10.10% |
| Dec 31, 2009 | 26.95M | -1.14M | -4.07% |
| Dec 31, 2008 | 28.10M | -682.16K | -2.37% |
| Dec 31, 2007 | 28.78M | 2.10M | 7.88% |
| Dec 31, 2006 | 26.68M | 6.47M | 31.99% |
| Dec 31, 2005 | 20.21M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 351.50M |
| Neuronetics | 151.64M |
| Quanterix | 144.98M |
| InfuSystem Holdings | 142.40M |
| RxSight | 127.48M |
| Owlet | 107.06M |
| AVITA Medical | 72.35M |
| CVRx, Inc. | 59.07M |
APYX News
- 1 day ago - Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - GlobeNewsWire
- 12 days ago - Apyx Medical initiated with a Buy at H.C. Wainwright - TheFly
- 15 days ago - Apyx Medical management to meet with Citizens - TheFly
- 4 weeks ago - Apyx Medical Proxy statement: Proxy filing - Filings
- 2 months ago - Apyx Medical Slides: Investor presentation - Filings
- 2 months ago - Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway - PRNewsWire
- 2 months ago - New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion® - GlobeNewsWire
- 2 months ago - Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction - GlobeNewsWire